SCHEMBL646140

SCHEMBL646140

CN(Cc1cc(Cl)ccc1C(N)=O)S(=O)(=O)c1cc(-c2nnc(O)n2-c2ccccc2Cl)c(O)cc1O

nearest known ligand 0.46

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 6/20 0.46
RPS6KB1 P23443 1/20 0.33
ALDH1A1 P00352 4/20 0.33
ADRA1D P25100 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.32
LMNA P02545 1/20 0.32
POLB P06746 1/20 0.32
TSHR P16473 1/20 0.32
MAPK1 P28482 1/20 0.32
HTT P42858 1/20 0.32
KEAP1 Q14145 3/20 0.32
NFE2L2 Q16236 3/20 0.32
CD38 P28907 1/20 0.32
HSP90AB1 P08238 2/20 0.31
NOTUM Q6P988 1/20 0.31
PARP1 P09874 1/20 0.31
CFTR P13569 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL644594 0.93 HSP90AA1 (0.39) HSP90AA1ALDH1A1ADRA1DHSP90AB1
SCHEMBL646303 0.93 HSP90AA1 (0.47) HSP90AA1ALDH1A1ADRA1DL3MBTL1HSP90AB1
SCHEMBL644660 0.88 HSP90AA1 (0.47) HSP90AA1ALDH1A1LMNAPOLBTSHR
SCHEMBL646642 0.87 HSP90AA1 (0.52) HSP90AA1ALDH1A1LMNAPOLBKEAP1
SCHEMBL646631 0.84 HSP90AA1 (0.47) HSP90AA1HSP90AB1
SCHEMBL646532 0.84 HSP90AA1 (0.49) HSP90AA1LMNAHSP90AB1
SCHEMBL645274 0.84 HSP90AA1 (0.49) HSP90AA1ALDH1A1KEAP1NFE2L2
SCHEMBL646245 0.84 HSP90AA1 (0.49) HSP90AA1ALDH1A1LMNAPOLBHSP90AB1
SCHEMBL646966 0.83 HSP90AA1 (0.52) HSP90AA1ALDH1A1LMNAPOLBHSP90AB1
SCHEMBL646699 0.83 HSP90AA1 (0.49) HSP90AA1ALDH1A1TSHRHTTKEAP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2023922-B1 TRIAZOLE DERIVATIVES II MERCK PATENT GMBH (DE) 2012-07-11 EP claimed
US-8119795-B2 Triazole derivatives II MERCK PATENT GMBH (DE) 2012-02-21 US claimed
US-20100022540-A1 TRIAZOLE DERIVATIVES II MERCK PATENT GESELLSCHAFT (DE) 2010-01-28 US claimed
EP-2023922-B1 TRIAZOLE DERIVATIVES II MERCK PATENT GMBH (DE) 2012-07-11 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100022540-A1 TRIAZOLE DERIVATIVES II HSP90AB1, HSP90AA1, HSP90AB2P HSP90AA1 2/4885RPS6KB1 28/4885ALDH1A1 1671/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.